CAS Number: 915087-33-1
Chemical Formula: C₂₁H₁₆F₄N₄O₂S
제형: 40 mg, 80 mg, 160 mg 함량으로 제공되는 필름코팅정이며 권장 용량은 1일 1회 160 mg
IUPAC Name: 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
EC Number: 805-022-1
Molecular Weight: 464.4
적응증: 전립선암 치료에 적응증이 있음
보관 조건: 30°C 이하에서 원래 포장 상태로 습기를 피해 보관

기타 정보

추가 설명:

Enzalutamide treats prostate cancer, available as film-coated tablets in 40 mg, 80 mg, and 160 mg strengths, with a recommended single daily dose of 160 mg. Coripharma is developing its generic version of enzalutamide at its R&D facility in Iceland, which runs entirely on sustainable energy, with the dossier planned for Q4 2026; its business development team is available to discuss opportunities.